AI Summary The ELF score comes from a blood test that measures three markers of liver scarring (HA, PIIINP, and TIMP-1) and combines them into one score from 0 to 10. Doctors use it to estimate fibrosis risk in chronic liver disease and track change without a biopsy. Below 7.7 is low risk, 7.7 to 9.8 is moderate, and above 9.8 suggests advanced fibrosis or cirrhosis needing specialist review. It estimates risk and does not diagnose or name the cause.
Source: www.liverdirectory.com
Medically Reviewed.
The ELF score comes from the Enhanced Liver Fibrosis (ELF) test. The test measures three substances in your blood that are linked to liver scarring (fibrosis). A lab combines them into one number from 0 to 10.
Doctors use it for people with chronic liver disease to check for advanced fibrosis or cirrhosis and to track changes over time. It is an estimate of risk, not a diagnosis.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
ENHANCED LIVER FIBROSIS TEST
The ELF score is the result of the Enhanced Liver Fibrosis (ELF) test. It is a blood test that estimates how much scar tissue, called fibrosis, has built up in your liver. You may also see it called the ELF test.
Routine liver enzyme tests mainly show liver cell injury. ELF looks at something different. It measures three substances involved in making and breaking down scar tissue. A lab combines them into one score from 0 to 10. A higher score points to more scarring.
The test needs only a blood sample. It is not a biopsy, and it can be repeated over time to show whether your fibrosis risk is changing.
ELF is one of the fibrosis scores. The others, such as FIB-3 and FIB-4 and the APRI score, use routine blood results instead. Your care team reads any of these scores together with your history and other tests.
FIBROSIS RISK ASSESSMENT
The ELF test answers one question: how likely is it that scarring in your liver is advanced? Doctors use the answer to plan monitoring and next steps.
ELF is useful for people with hepatitis B or C, [fatty liver disease](/liver-diseases/metabolic-liver-diseases/fatty-liver-disease), or alcohol-related liver disease. Fatty liver disease is now often called MASLD (metabolic dysfunction-associated steatotic liver disease). In these conditions, long-term injury can slowly build scar tissue.
Serious complications, such as liver decompensation, portal hypertension problems, and liver cancer, mostly occur in people with advanced fibrosis. Finding advanced scarring early helps guide monitoring and the need to see a specialist.
A [liver biopsy](/liver-tests/invasive-testing/liver-biopsy) can cause pain and bleeding, and rarely more serious problems. Blood-based tests are safer and easier to repeat. Biopsy stays an option when non-invasive results are unclear.
Because ELF needs only a blood sample, it can be repeated. Doctors compare results to see whether fibrosis risk is improving, staying stable, or getting worse, including after treatment begins.
BLOOD MARKERS EXPLAINED
A lab measures three substances in your blood. Each one reflects a different part of how the liver builds and clears scar tissue. Together they form a single score.
HA is a substance made during liver fibrosis. Higher levels can point to more scarring.
PIIINP stands for procollagen III amino-terminal peptide. It reflects collagen production in the liver. Collagen is the main building material of scar tissue.
TIMP-1 stands for tissue inhibitor of metalloproteinase-1. It reflects reduced breakdown of scar tissue.
A mathematical formula combines the three results into one number from 0 to 10. You do not need to calculate it. The lab reports the score, and your care team explains it.
RISK CUTOFFS EXPLAINED
The ELF score runs from 0 to 10. Labs and doctors may use slightly different cutoffs, so ask your care team how they read your number.
A combined score from three blood markers of liver scarring. Higher numbers mean a higher chance of advanced fibrosis.
0 to 10 scale
Below 7.7 is low risk. There is minimal or no significant fibrosis, and the liver is generally healthy or only mildly affected.
7.7 to 9.8 is moderate risk. Fibrosis may be moderate. Monitoring or more testing, such as FibroScan, ultrasound, or other imaging, may be recommended.
Above 9.8 is high risk. This suggests advanced fibrosis or cirrhosis. Specialist evaluation and management are usually needed.
Your ELF score helps estimate risk. Your doctor interprets it with your symptoms, other blood tests, and imaging.
NON-INVASIVE TEST OPTIONS
No single test fits every person. Doctors often use these tests in steps.
| Test | What it uses | Procedure needed |
|---|---|---|
| ELF score | Three fibrosis markers in blood: HA, PIIINP, and TIMP-1 | Blood draw |
| FIB-4 and APRI | Routine blood results such as AST, platelets, and (for FIB-4) age and ALT | Blood draw |
| FibroScan (transient elastography) | Liver stiffness measured with an ultrasound-like device | Quick, painless scan |
| Liver biopsy | A small sample of liver tissue studied under a microscope | Needle procedure |
For fatty liver disease, a common approach is to start with a simple score such as FIB-4. A positive result can then be confirmed with FibroScan, MRE, or ELF, depending on availability. Biopsy is considered when results are unclear.
FOLLOW-UP AFTER TESTING
What happens next depends on your score and on the liver condition you have.
This points to minimal or no significant fibrosis. Your doctor may keep monitoring you on a schedule that fits your liver condition. Lifestyle habits still matter, especially if you have fatty liver disease, where diet, activity, and weight loss are the foundation of care.
Your doctor may suggest more testing, such as FibroScan, ultrasound, or other imaging. Repeat ELF tests can show whether your score is moving. If you have MASH with moderate-to-advanced fibrosis, ask whether a therapy such as [resmetirom](/liver-therapies/metabolic-masld-mash-therapies/thr-beta-agonist-therapy/resmetirom) fits your situation.
This suggests advanced fibrosis or cirrhosis. Specialist evaluation is usually needed. A liver specialist can confirm the stage, check for complications, and plan treatment and monitoring.
TEST LIMITATIONS TO KNOW
ELF estimates how much scarring may be present. It does not show why the liver is scarred. Your care team uses your history and other tests to find the cause.
ELF looks particularly suitable for people with fatty liver disease and alcohol-related liver disease. Earlier evaluations found it less suitable for people with hepatitis C infection. Ask your doctor whether it fits your condition.
When non-invasive results are unclear or do not match the rest of your picture, your doctor may suggest a [liver biopsy](/liver-tests/invasive-testing/liver-biopsy). Biopsy remains the gold standard for staging fibrosis in these cases.
A balanced, liver-friendly diet supports your liver, helps manage weight and blood sugar, and lowers the risk of other health problems during long-term follow-up.
Explore Liver DietThe Amsety Bar is a liver-friendly snack or meal replacement that can make it easier to eat well on busy days.
Shop Amsety Bars
Common Questions
An ELF score below 7.7 is low risk. The score runs from 0 to 10, and a lower number means less scarring. Here is how the ranges break down: - **Below 7.7 (low risk):** Minimal or no significant fibrosis. The liver is generally healthy or only mildly affected. - **7.7 to 9.8 (moderate risk):** Fibrosis may be moderate. Your doctor may suggest monitoring or more testing, such as FibroScan, ultrasound, or other imaging. - **Above 9.8 (high risk):** This suggests advanced fibrosis or cirrhosis. Labs and doctors may use slightly different cutoffs. Your doctor reads your number alongside your history and other tests, so ask what it means for you.
A high ELF score, above 9.8, suggests advanced fibrosis or cirrhosis. Fibrosis is scar tissue in the liver, and cirrhosis is the most advanced stage of scarring. A high score usually means you need specialist evaluation and management. A liver specialist can confirm the stage, check for complications, and plan treatment and monitoring. The score is a risk estimate, not a diagnosis. Your doctor may confirm it with other tests, such as FibroScan or other imaging. When results are unclear, a liver biopsy may be considered.
The ELF test measures three markers in a blood sample that are linked to liver scarring. Each one reflects a different part of how the liver builds and clears scar tissue. - **Hyaluronic acid (HA):** A substance produced during liver fibrosis. - **PIIINP:** A marker of collagen production in the liver. Collagen is the main building material of scar tissue. - **TIMP-1:** A marker of reduced breakdown of scar tissue. A lab combines the three results with a formula into one score from 0 to 10. You do not need to calculate it yourself. The lab reports the score, and your care team explains it.
ELF measures fibrosis markers directly, while FIB-4 is calculated from routine results. Both are blood-based and need no procedure. - **ELF** measures three markers of scar tissue: HA, PIIINP, and TIMP-1. It gives a score from 0 to 10. - **FIB-4** combines your age, AST, ALT, and platelet count. These come from routine blood tests. For fatty liver disease, a common approach is to start with a simple score such as FIB-4. A positive result can then be confirmed with FibroScan, MRE, or ELF, depending on availability. Your doctor chooses based on your condition and what is available. To learn more, see [FIB-3 and FIB-4 scores](/liver-tests/medical-scores/fibrosis-scores/fib-3-fib-4).
No, an ELF score cannot diagnose cirrhosis on its own. It can show your risk of advanced fibrosis or cirrhosis, but it does not confirm either one. A diagnosis also depends on your medical history, symptoms, other blood tests, and imaging. Sometimes a liver biopsy is needed when non-invasive results are unclear or do not match the rest of your picture. If your score is high, ask your care team what testing should come next and whether you should see a liver specialist.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
